Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SOCS3 as a new therapeutic target in breast cancer

July 23, 2020

First patient dosed in phase II study of taletrectinib in NSCLC with ROS1 fusion

July 22, 2020

Shanghai Dude Medical Science and Technology discovers TRK inhibitors

July 22, 2020

FORMA Therapeutics synthesizes USP9X inhibitors

July 22, 2020

Newave Pharmaceutical divulges Bcl-2 inhibitors

July 22, 2020

Agios Pharmaceuticals presents Mat2A inhibitors

July 22, 2020

Hillstream Biopharma presents preclinical data for HSB-1216 in cancer

July 21, 2020

Positive interim efficacy and safety data presented for BNZ-1

July 21, 2020

FORMA Therapeutics patents USP1 inhibitors

July 21, 2020

Agios Pharmaceuticals divulges MAT2A inhibitors

July 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...